Journal of Cardiac Failure
Volume 15, Issue 6 , Pages 529-539 , August 2009

Cardiac Cell-specific Apoptotic and Cytokine Responses to Reovirus Infection: Determinants of Myocarditic Phenotype

  • Shelley D. Miyamoto, MD

      Affiliations

    • Department of Pediatrics, University of Colorado Denver Health Sciences Center, Denver, Colorado
    • Corresponding Author InformationReprint requests: Shelley Miyamoto, MD, 13123 E. 16th Avenue, B100, The Children's Hospital, Aurora, CO 80045. Tel.: (720) 777-3218; Fax: (720) 777-7287.
    • ,
  • R.D. Brown, PhD

      Affiliations

    • Department of Medicine, University of Colorado Denver Health Sciences Center, Denver, Colorado
    • ,
  • Bridget A. Robinson, BS

      Affiliations

    • Department of Pediatrics, University of Colorado Denver Health Sciences Center, Denver, Colorado
    • ,
  • Kenneth L. Tyler, MD

      Affiliations

    • Department of Medicine, University of Colorado Denver Health Sciences Center, Denver, Colorado
    • Department of Neurology, University of Colorado Denver Health Sciences Center, Denver, Colorado
    • Department of Microbiology, University of Colorado Denver Health Sciences Center, Denver, Colorado
    • Neurology Service, Denver Veterans Affairs Medical Center, Denver, Colorado
    • ,
  • Carlin S. Long, MD

      Affiliations

    • Department of Medicine, University of Colorado Denver Health Sciences Center, Denver, Colorado
    • ,
  • Roberta L. Debiasi, MD

      Affiliations

    • Department of Pediatrics, University of Colorado Denver Health Sciences Center, Denver, Colorado
    • Department of Pediatrics, The George Washington University School of Medicine and Health Sciences and Children's National Medical Center, Washington, DC

Received 7 August 2008 ,Revised 30 December 2008 ,Accepted 20 January 2009.

References 

  1. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343:1388–1398
  2. Mason JW. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res. 2003;60:5–10
  3. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005;112:1965–1970
  4. Lauer B, Schannwell M, Kuhl U, Strauer BE, Schultheiss HP. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol. 2000;35:11–18
  5. Nishii M, Inomata T, Takehana H, Takeuchi I, Nakano H, Koitabashi T, et al. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol. 2004;44:1292–1297
  6. Sheppard R, Bedi M, Kubota T, Semigran MJ, Dec W, Holubkov R, et al. Myocardial expression of fas and recovery of left ventricular function in patients with recent-onset cardiomyopathy. J Am Coll Cardiol. 2005;46:1036–1042
  7. Yamamoto K, Shioi T, Uchiyama K, Miyamoto T, Sasayama S, Matsumori A. Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice. J Am Coll Cardiol. 2003;42:2000–2006
  8. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3–14
  9. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006;113:593–595
  10. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation. 1999;99:1091–1100
  11. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001;104:1076–1082
  12. Huber S. Cellular autoimmunity in myocarditis. Heart Fail Clin. 2005;1:321–331
  13. Sherry B, Baty CJ, Blum MA. Reovirus-induced acute myocarditis in mice correlates with viral RNA synthesis rather than generation of infectious virus in cardiac myocytes. J Virol. 1996;70:6709–6715
  14. Spandidos DA, Graham AF. Generation of defective virus after infection of newborn rats with reovirus. J Virol. 1976;20:234–247
  15. Bennette JG, Bush PV, Steele RD. Characteristics of a newborn runt disease induced by neonatal infection with an oncolytic strain of reovirus type 3 (REO3MH). II. Immunological aspects of the disease in mice. Br J Exp Pathol. 1967;48:267–284
  16. Kilham L, Margolis G. Hydrocephalus in hamsters, ferrets, rats, and mice following inoculations with reovirus type I.I. Virologic studies. Lab Invest. 1969;21:183–188
  17. Lussier G, Descoteaux JP. Prevalence of natural virus infections in laboratory mice and rats used in Canada. Lab Anim Sci. 1986;36:145–148
  18. Farone AL, Frevert CW, Farone MB, Morin MJ, Fields BN, Paulauskis JD, et al. Serotype-dependent induction of pulmonary neutrophilia and inflammatory cytokine gene expression by reovirus. J Virol. 1996;70:7079–7084
  19. Morin MJ, Warner A, Fields BN. Reovirus infection in rat lungs as a model to study the pathogenesis of viral pneumonia. J Virol. 1996;70:541–548
  20. DeBiasi RL, Edelstein CL, Sherry B, Tyler KL. Calpain inhibition protects against virus-induced apoptotic myocardial injury. J Virol. 2001;75:351–361
  21. DeBiasi RL, Robinson BA, Sherry B, Bouchard R, Brown RD, Rizeq M, et al. Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol. 2004;78:11040–11050
  22. Debiasi RL, Squier MK, Pike B, Wynes M, Dermody TS, Cohen JJ, et al. Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J Virol. 1999;73:695–701
  23. Sherry B. Pathogenesis of reovirus myocarditis. Curr Top Microbiol Immunol. 1998;233:51–66
  24. Sherry B, Blum MA. Multiple viral core proteins are determinants of reovirus-induced acute myocarditis. J Virol. 1994;68:8461–8465
  25. Sherry B, Fields BN. The reovirus M1 gene, encoding a viral core protein, is associated with the myocarditic phenotype of a reovirus variant. J Virol. 1989;63:4850–4856
  26. Sherry B, Schoen FJ, Wenske E, Fields BN. Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol. 1989;63:4840–4849
  27. Baty CJ, Sherry B. Cytopathogenic effect in cardiac myocytes but not in cardiac fibroblasts is correlated with reovirus-induced acute myocarditis. J Virol. 1993;67:6295–6298
  28. Hassan SA, Rabin ER, Melnick JL. Reovirus myocarditis in mice: an electron microscopic, immunofluorescent, and virus assay study. Exp Mol Pathol. 1965;76:66–80
  29. Sherry B, Li XY, Tyler KL, Cullen JM, Virgin HWT. Lymphocytes protect against and are not required for reovirus-induced myocarditis. J Virol. 1993;67:6119–6124
  30. Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42:466–472
  31. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257
  32. Nakamura M, Wang NP, Zhao ZQ, Wilcox JN, Thourani V, Guyton RA, et al. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res. 2000;45:661–670
  33. Kyto V, Saraste A, Saukko P, Henn V, Pulkki K, Vuorinen T, et al. Apoptotic cardiomyocyte death in fatal myocarditis. Am J Cardiol. 2004;94:746–750
  34. Kyto V, Lapatto R, Lakkisto P, Saraste A, Voipio-Pulkki LM, Vuorinen T, et al. Glutathione depletion and cardiomyocyte apoptosis in viral myocarditis. Eur J Clin Invest. 2004;34:167–175
  35. Colston JT, Chandrasekar B, Freeman GL. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis. Cardiovasc Res. 1998;38:158–168
  36. Saraste A, Arola A, Vuorinen T, Kyto V, Kallajoki M, Pulkki K, et al. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc Pathol. 2003;12:255–262
  37. Joo CH, Hong HN, Kim EO, Im JO, Yoon SY, Ye JS, et al. Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains. Intervirology. 2003;46:135–140
  38. Stewart MJ, Smoak K, Blum MA, Sherry B. Basal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response. J Virol. 2005;79:2979–2987
  39. Stewart MJ, Blum MA, Sherry B. PKR's protective role in viral myocarditis. Virology. 2003;314:92–100
  40. Long CS, Brown RD. The cardiac fibroblast, another therapeutic target for mending the broken heart?. J Mol Cell Cardiol. 2002;34:1273–1278
  41. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol. 2005;45:657–687
  42. Sherry B, Torres J, Blum MA. Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins. J Virol. 1998;72:1314–1323
  43. Long CS, Henrich CJ, Simpson PC. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Regul. 1991;2:1081–1095
  44. Koudssi F, Lopez JE, Villegas S, Long CS. Cardiac fibroblasts arrest at the G1/S restriction point in response to interleukin (IL)-1beta. Evidence for IL-1beta-induced hypophosphorylation of the retinoblastoma protein. J Biol Chem. 1998;273:25796–25803
  45. Tyler KL, Bronson RT, Byers KB, Fields B. Molecular basis of viral neurotropism: experimental reovirus infection. Neurology. 1985;35:88–92
  46. Kinugawa K, Minobe WA, Wood WM, Ridgway EC, Baxter JD, Ribeiro RC, et al. Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression. Circulation. 2001;103:1089–1094
  47. Patten M, Hartogensis WE, Long CS. Interleukin-1beta is a negative transcriptional regulator of alpha1-adrenergic induced gene expression in cultured cardiac myocytes. J Biol Chem. 1996;271:21134–21141
  48. Shioi T, Matsumori A, Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation. 1996;94:2930–2937
  49. Long CS. The role of interleukin-1 in the failing heart. Heart Fail Rev. 2001;6:81–94
  50. Yue P, Massie BM, Simpson PC, Long CS. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol. 1998;275:H250–H258
  51. Kajstura J, Zhang X, Reiss K, Szoke E, Li P, Lagrasta C, et al. Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res. 1994;74:383–400
  52. Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 1995;91:1520–1524
  53. Turner NA, Mughal RS, Warburton P, O'Regan DJ, Ball SG, Porter KE. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. Cardiovasc Res. 2007;76:81–90
  54. Lim BK, Choe SC, Shin JO, Ho SH, Kim JM, Yu SS, et al. Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis. Circulation. 2002;105:1278–1281
  55. Kanda T, McManus JE, Nagai R, Imai S, Suzuki T, Yang D, et al. Modification of viral myocarditis in mice by interleukin-6. Circ Res. 1996;78:848–856
  56. Nishio R, Matsumori A, Shioi T, Ishida H, Sasayama S. Treatment of experimental viral myocarditis with interleukin-10. Circulation. 1999;100:1102–1108
  57. Kanda T, Tanaka T, Sekiguchi K, Seta Y, Kurimoto M, Wilson McManus JE, et al. Effect of interleukin-18 on viral myocarditis: enhancement of interferon- gamma and natural killer cell activity. J Mol Cell Cardiol. 2000;32:2163–2171
  58. Azzam-Smoak K, Noah DL, Stewart MJ, Blum MA, Sherry B. Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis. Virology. 2002;298:20–29
  59. Noah DL, Blum MA, Sherry B. Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures. J Virol. 1999;73:10208–10213
  60. Brown R.D. AM, Polizzi SM, Long CS. Cytokines regulate inflammatory and fibrotic gene programs in rat cardiac fibroblasts. [abstract] FASEB J. 2003;17:A1359
  61. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077–1084
  62. Dec GW, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;312:885–890
  63. Ardehali H, Kasper EK, Baughman KL. Diagnostic approach to the patient with cardiomyopathy: whom to biopsy. Am Heart J. 2005;149:7–12
  64. Martin AB, Webber S, Fricker FJ, Jaffe R, Demmler G, Kearney D, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation. 1994;90:330–339
  65. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kuhl U, Schwimmbeck PL, et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation. 1999;99:1348–1354
  66. Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation. 1994;89:2582–2589
  67. Fujioka S, Kitaura Y, Ukimura A, Deguchi H, Kawamura K, Isomura T, et al. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000;36:1920–1926
  68. Chan KY, Iwahara M, Benson LN, Wilson GJ, Freedom RM. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. J Am Coll Cardiol. 1991;17:458–460
  69. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333:269–275
  70. Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med. 1989;321:1061–1068
  71. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathologic description of myocarditis. J Am Coll Cardiol. 1991;18:1617–1626

 R.L. DeBiasi was previously affiliated with UCHSC at the initiation of this work, but is currently affiliated with GWU/CNMC.

 Supported by the Research Scholar Award, The Children's Hospital, Denver, CO (S.M.); VA MERIT and NIH R01 NS051403 and NS050138 (K.T.); NIH HL59428 and HL79160 (C.L.); NIH K08 AI052261-05 (R.D.).

PII: S1071-9164(09)00019-0

doi: 10.1016/j.cardfail.2009.01.004

Journal of Cardiac Failure
Volume 15, Issue 6 , Pages 529-539 , August 2009

Article Tools

* Image Usage & Resolution